An Arizona jury on Thursday sentenced a man to death in a string of killings in metro Phoenix during a three-week span in 2017, marking the end of a seven-month trial over attacks that targeted random ...

It's the end of an era, and Taylor Swift is memorializing her sprawling, record-breaking world tour with a six-part documentary series and full concert film. We've compiled absolutely everything you ...

A record-breaking number of Americans are expected to hit the road this Christmas season, prompting AAA to release new guidance on when drivers should—and shouldn’t—travel to avoid the worst holiday ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Taylor Swift revealed her nighttime routine after performing the Eras Tour. We found all the products on ...

I work in a progressive public school in a small department where I am the only man. Much of my time is spent in meetings where there is an ever-present thread of, quite frankly, misandrist commentary ...

Ready for a howling good time? With more than 180 breeds ready to show off, the National Dog Show returns on Thursday, Nov. 27, following the Macy's Day Thanksgiving Day Parade. The stellar pet event ...

Christine is a freelance writer for Collider with two decades of experience covering all types of TV shows and movies spanning every genre. With a particular affinity for dramas, true crime, sitcoms, ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Abbott Laboratories ABT0.26%increase; green up pointing triangle agreed to acquire cancer diagnostics company Exact Sciences EXAS 0.43%increase; green up pointing triangle in a deal valued at about ...

North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...

The pending $23 billion sale of Madison-based Exact Sciences to health care giant Abbott centers on Exact Sciences' flagship product: colorectal cancer test Cologuard. Exact Sciences markets Cologuard ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...